Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis.

[1]  M. Phipps,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[2]  L. Peirson,et al.  Treatment of overweight and obesity in children and youth: a systematic review and meta-analysis. , 2015, CMAJ open.

[3]  L. Peirson,et al.  Prevention of overweight and obesity in children and youth: a systematic review and meta-analysis. , 2015, CMAJ open.

[4]  L. Peirson,et al.  Prevention of overweight and obesity in adult populations: a systematic review. , 2014, CMAJ open.

[5]  M. Hernán,et al.  Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. , 2014, JAMA.

[6]  T. Levin,et al.  Accuracy of Fecal Immunochemical Tests for Colorectal Cancer , 2014, Annals of Internal Medicine.

[7]  Aasma Shaukat,et al.  Long-term mortality after screening for colorectal cancer. , 2013, The New England journal of medicine.

[8]  D. Hughes,et al.  An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[9]  Sean Wallis,et al.  Binomial Confidence Intervals and Contingency Tests: Mathematical Fundamentals and the Evaluation of Alternative Methods , 2013, J. Quant. Linguistics.

[10]  C. Shun,et al.  Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  B. Denis,et al.  Harms of colonoscopy in a colorectal cancer screening programme with faecal occult blood test: a population-based cohort study. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[12]  O. Lantieri,et al.  A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening. , 2013, Gastroenterology.

[13]  Christian Stock,et al.  Adverse events requiring hospitalization within 30 days after outpatient screening and nonscreening colonoscopies. , 2013, Gastrointestinal endoscopy.

[14]  George A Kelley,et al.  Statistical models for meta-analysis: A brief tutorial. , 2012, World journal of methodology.

[15]  Mark P Purdue,et al.  Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. , 2012, The New England journal of medicine.

[16]  P. Bossuyt,et al.  Paper alert , 2012, Gastroenterology.

[17]  L. Jandorf,et al.  Effect of Comorbid Conditions on Adherence to Colorectal Cancer Screening , 2012, Journal of Cancer Education.

[18]  C. von Wagner,et al.  Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests , 2010, Gut.

[19]  D. Miglioretti,et al.  Adverse events after screening and follow-up colonoscopy , 2011, Cancer Causes & Control.

[20]  C M Mangham,et al.  Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up , 2011, Gut.

[21]  L. Bisanti,et al.  Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. , 2011, Journal of the National Cancer Institute.

[22]  T. Ganiats,et al.  Cost-effectiveness of a mailed educational reminder to increase colorectal cancer screening , 2011, BMC gastroenterology.

[23]  Y. Niv,et al.  A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study , 2011, International journal of cancer.

[24]  L. Glória,et al.  Acute lower gastrointestinal bleeding management in Portugal: a multicentric prospective 1-year survey , 2011, European journal of gastroenterology & hepatology.

[25]  A. Levy,et al.  The cost-effectiveness of screening for colorectal cancer , 2010, Canadian Medical Association Journal.

[26]  S. Ryu,et al.  Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer Screening , 2010, The American Journal of Gastroenterology.

[27]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[28]  Cesare Hassan,et al.  Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[29]  David H. Kim,et al.  CT colonography: performance and program outcome measures in an older screening population. , 2010, Radiology.

[30]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening—Age to Begin, Age to Stop, and Timing of Screening Intervals , 2009 .

[31]  J. Wilson,et al.  Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer , 2008, Gut.

[32]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[33]  Rongwei Fu,et al.  Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[34]  C. Lepage,et al.  Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. , 2008, European journal of cancer.

[35]  E. Haglind,et al.  Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer , 2008, The British journal of surgery.

[36]  T. Chen,et al.  Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16) , 2007, Journal of medical screening.

[37]  M Westwood,et al.  Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review , 2007, Journal of medical screening.

[38]  J. Olynyk,et al.  Outcomes after 10 years of a community‐based flexible sigmoidoscopy screening program for colorectal carcinoma , 2007, The Medical journal of Australia.

[39]  A. Pezzoli,et al.  Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience , 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[40]  B. Denis,et al.  Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test , 2007, Gut.

[41]  P. Pickhardt.  Incidence of colonic perforation at CT colonography: review of existing data and implications for screening of asymptomatic adults. , 2006, Radiology.

[42]  Erle Kirby,et al.  Colorectal cancer detection in a rural community. Development of a colonoscopy screening program. , 2005, Canadian family physician Medecin de famille canadien.

[43]  B. Leggett,et al.  Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community , 2005, Australian and New Zealand journal of public health.

[44]  L. Bisanti,et al.  Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. , 2005, Journal of the National Cancer Institute.

[45]  R. Kozarek,et al.  Screening Colonoscopy in Chinese and Western Patients: A Comparative Study , 2004, The American Journal of Gastroenterology.

[46]  C. Ko,et al.  A population‐based study of colorectal cancer test use , 2004, Cancer.

[47]  R. Steele,et al.  Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom , 2004, BMJ : British Medical Journal.

[48]  J. Faivre,et al.  Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. , 2004, Gastroenterology.

[49]  O. Kronborg,et al.  Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds , 2004, Scandinavian journal of gastroenterology.

[50]  M. Bretthauer,et al.  The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. , 2003, Scandinavian journal of gastroenterology.

[51]  Justin C.Y. Wu,et al.  Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. , 2003, Gastroenterology.

[52]  Xiyong Liu,et al.  Cluster Randomization Trial of Sequence Mass Screening for Colorectal Cancer , 2003, Diseases of the colon and rectum.

[53]  C. Crosta,et al.  Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE. , 2002, Journal of the National Cancer Institute.

[54]  J. Selby,et al.  Complications of screening flexible sigmoidoscopy. , 2002, Gastroenterology.

[55]  Michael Pignone,et al.  Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[56]  Ankur Jain,et al.  Outcome of 5,000 flexible sigmoidoscopies done by nurse endoscopists for colorectal screening in asymptomatic patients. , 2002, Hawaii medical journal.

[57]  J. Wardle,et al.  Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial , 2002, The Lancet.

[58]  D. Lieberman,et al.  Procedural success and complications of large-scale screening colonoscopy. , 2002, Gastrointestinal endoscopy.

[59]  P. Fuglerud,et al.  Screening of First Degree Relatives of Patients Operated for Colorectal Cancer: Evaluation of Fecal Calprotectin vs. Hemoccult II , 2001, Digestion.

[60]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.